Navigation Links
SYNCHRON CX®7 Super

ProductsSYNCHRON CX®7 Super
Company Beckman Coulter, Inc.
Item SYNCHRON CX®7 Super
Features 
  • 32 onboard chemistries
  • 825 tests per hour throughput
  • Up to 63 sample capacity with continuous loading capability
  • Onboard reagent stability of up to 60 days (up to 90 days for electrolyte reagents)
  • Automatic tracking of bar-coded reagents number of tests available, expiration date, lot number, cartridge ID number, onboard dating and calibration status
  • Easy to use
  • Continuous random access for samples, controls calibrators and results
  • No-wait autoloader
  • 100 bar-coded, liquid analytes, most ready-to-use
  • Bar-coded calibrators and controls
  • Advanced data management improves productivity
  • Easy to maintain
  • Factory reconditioning means improved reliability
  • 4 Ion-selective electrodes improve speed and reduce maintenance
  • No-maintenance glucose oxygen sensor
  • Long-lasting (more than 5 years) pulsed Xenon lamp reduces calibration and maintenance
  • Easy to acquire.
  • Affordable systems from an industry leader
  • Combine with Access® and the COULTER® MAXM™ for the complete pathology lab solution
Description The SYNCHRON CX7-S workstation offers a broad menu, advanced data management and more. Targeted to the mid-volume lab, the CX7-S is easy to use, easy to maintain and easy to acquire.
Info Beckman Coulter, Inc.
Customer Service: (800) 742-2345

Related medicine products :

1. SYNCHRON CX® 4 Delta
2. SYNCHRON CX 3 Delta
3. SYNCHRON CX 4 PRO
4. SYNCHRON LX® 2000 PRO
5. SYNCHRON CX5 PRO
6. SYNCHRON® CX500 PRO System
7. SYNCHRON LX®20 PRO
8. SYNCHRON CX® 1000 PRO Clinical System
9. SYNCHRON CX®9 PRO Clinical System
10. SYNCHRON LX4201
11. SYNCHRON LX® 20
... Magnetic separation is a method for ... acids and cells using affinity binding, ... been coated on the particles to ... To remove the MagnaBind™ Beads from ...
QuantumPlex is a bead kit for multiple analyte-detection research applications in flow cytometry. The beads may be analyzed with any standard cytometer and do not require the use of specialized softw...
... Streptavidin magnetic beads ... beads covalently coupled to ... Captured substrates can be ... subsequent experiments including mRNA ...
... The OptiMAL® assay is a ... assay that permits the detection ... human malaria; and can distinguish ... and P. vivax . ...
Medicine Products:
(Date:5/24/2016)... ... May 24, 2016 , ... Researchers from ... protocols designed to reduce bleeding complications from percutaneous coronary intervention (PCI). The data, ... (SCAI) in Orlando, FL, document a 40% reduction in risk-adjusted bleeding event rates ...
(Date:5/24/2016)... LONGMONT, CO (PRWEB) , ... ... ... Essette’s official announcement of Essette Dashboard, its highly anticipated, web-based software module. ... visualization platform. The application’s “secret sauce”? Integration with Izenda’s self-service business intelligence ...
(Date:5/23/2016)... ... May 23, 2016 , ... On Sunday, ... new $11.5 million, 64-room assisted living center. After 18 months of construction, the ... , The new building provides the latest in assisted living amenities and services, ...
(Date:5/23/2016)... Los Angeles, CA (PRWEB) , ... May 23, 2016 , ... ... bariatric surgeons have noted that, less than 1% of United Kingdom residents who could ... the UK’s National Health Service (NHS) increases the number of bariatric procedures it offers ...
(Date:5/23/2016)... ... May 23, 2016 , ... ... and sexual objectification, according to Georgia State University researchers. , In ... in the fifth, sixth and seventh grades shared their experiences with strained ...
Breaking Medicine News(10 mins):
(Date:5/19/2016)... According to a new market research report "Sunitinib Malate ... Germany , France , U.K., ... Japan )", published by MarketsandMarkets, The market is projected to ... from 2016 to 2021.      (Logo: http://photos.prnewswire.com/prnh/20160303/792302 ... through 26 Pages and in-depth TOC on "Sunitinib Malate ...
(Date:5/19/2016)... , May 19, 2016 , The ... (a bstract # 8006)   The ... of the treated patients with 90% of the ... six months or more . Seventy two percent of the patients had ... (MSE:PHM) announces the positive results from a Phase I study of plitidepsin in ...
(Date:5/19/2016)... NEW YORK , May 19, 2016 ... one sector that is always abounding of surprises is without ... the Healthcare sector ahead of today,s trading session: Alkermes PLC ... AMAG ), IDEXX Laboratories Inc. (NASDAQ: IDXX ... Sign up for your complimentary alerts at: ...
Breaking Medicine Technology: